ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $676,618 | -50.2% | 51,493 | -52.2% | 0.00% | 0.0% |
| Q2 2023 | $1,357,347 | +60.6% | 107,726 | +66.4% | 0.00% | 0.0% |
| Q1 2023 | $845,040 | -38.7% | 64,754 | -17.2% | 0.00% | 0.0% |
| Q4 2022 | $1,378,724 | +32.8% | 78,159 | +14.8% | 0.00% | 0.0% |
| Q3 2022 | $1,038,000 | +7.8% | 68,107 | +4.9% | 0.00% | 0.0% |
| Q2 2022 | $963,000 | -64.0% | 64,930 | -45.4% | 0.00% | -50.0% |
| Q1 2022 | $2,678,000 | +24.3% | 118,927 | +1.8% | 0.00% | +100.0% |
| Q4 2021 | $2,155,000 | +76.9% | 116,770 | +28.2% | 0.00% | 0.0% |
| Q3 2021 | $1,218,000 | -47.7% | 91,104 | -27.6% | 0.00% | 0.0% |
| Q2 2021 | $2,328,000 | -0.4% | 125,796 | -19.2% | 0.00% | -50.0% |
| Q1 2021 | $2,338,000 | +103.5% | 155,678 | +95.7% | 0.00% | +100.0% |
| Q4 2020 | $1,149,000 | +70.2% | 79,540 | -4.0% | 0.00% | – |
| Q3 2020 | $675,000 | -28.4% | 82,886 | -40.5% | 0.00% | -100.0% |
| Q2 2020 | $943,000 | -51.2% | 139,357 | -49.2% | 0.00% | -50.0% |
| Q1 2020 | $1,933,000 | -51.4% | 274,585 | -32.2% | 0.00% | 0.0% |
| Q4 2019 | $3,975,000 | -42.4% | 405,045 | -35.5% | 0.00% | -60.0% |
| Q3 2019 | $6,896,000 | -50.3% | 628,016 | -47.4% | 0.01% | -58.3% |
| Q2 2019 | $13,884,000 | +139.6% | 1,193,863 | +96.6% | 0.01% | +100.0% |
| Q1 2019 | $5,794,000 | +8.0% | 607,328 | +9.1% | 0.01% | +20.0% |
| Q4 2018 | $5,365,000 | -64.1% | 556,436 | -46.9% | 0.01% | -61.5% |
| Q3 2018 | $14,932,000 | +16.0% | 1,047,878 | -2.3% | 0.01% | +8.3% |
| Q2 2018 | $12,867,000 | +42.3% | 1,072,272 | +46.5% | 0.01% | +71.4% |
| Q1 2018 | $9,041,000 | -50.2% | 732,042 | -41.3% | 0.01% | -50.0% |
| Q4 2017 | $18,154,000 | +10.7% | 1,247,651 | +8.3% | 0.01% | +7.7% |
| Q3 2017 | $16,401,000 | -11.1% | 1,152,558 | -20.3% | 0.01% | -23.5% |
| Q2 2017 | $18,451,000 | +24.0% | 1,446,027 | +23.2% | 0.02% | +30.8% |
| Q1 2017 | $14,881,000 | +1.0% | 1,173,599 | -18.6% | 0.01% | 0.0% |
| Q4 2016 | $14,728,000 | +1.3% | 1,442,502 | +30.7% | 0.01% | -7.1% |
| Q3 2016 | $14,535,000 | +16.7% | 1,103,652 | +12.5% | 0.01% | +7.7% |
| Q2 2016 | $12,456,000 | -0.9% | 980,763 | +3.1% | 0.01% | -7.1% |
| Q1 2016 | $12,566,000 | -9.0% | 951,337 | +6.0% | 0.01% | 0.0% |
| Q4 2015 | $13,809,000 | +23.7% | 897,838 | -0.3% | 0.01% | +40.0% |
| Q3 2015 | $11,162,000 | -11.4% | 900,203 | -2.2% | 0.01% | -9.1% |
| Q2 2015 | $12,597,000 | +13.9% | 920,795 | -0.4% | 0.01% | 0.0% |
| Q1 2015 | $11,056,000 | +32.9% | 924,462 | +42.0% | 0.01% | +57.1% |
| Q4 2014 | $8,316,000 | +3.2% | 651,179 | +8.4% | 0.01% | 0.0% |
| Q3 2014 | $8,060,000 | +1480.4% | 600,871 | +1790.4% | 0.01% | – |
| Q2 2014 | $510,000 | -95.9% | 31,786 | -95.4% | 0.00% | -100.0% |
| Q1 2014 | $12,465,000 | -11.8% | 691,299 | -24.4% | 0.01% | 0.0% |
| Q4 2013 | $14,134,000 | +16.4% | 914,237 | +12.0% | 0.01% | +18.2% |
| Q3 2013 | $12,138,000 | +1022.8% | 816,270 | +877.0% | 0.01% | +1000.0% |
| Q2 2013 | $1,081,000 | – | 83,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,500,000 | $21,593,000 | 4.50% |
| KESTREL INVESTMENT MANAGEMENT CORP | 445,500 | $6,433,000 | 3.14% |
| Adirondack Research & Management Inc. | 155,088 | $2,239,000 | 3.06% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 9,398,617 | $135,716,029,000 | 2.92% |
| Waterfront Wealth Inc. | 136,976 | $1,978,000 | 1.40% |
| Smith, Graham & Co., Investment Advisors, LP | 1,008,283 | $14,560,000 | 1.34% |
| S&T BANK/PA | 475,184 | $6,862,000 | 1.23% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,132,500 | $16,354,000 | 0.98% |
| HENNESSY ADVISORS INC | 1,024,100 | $14,788,000 | 0.95% |
| BEACONLIGHT CAPITAL, LLC | 208,546 | $3,011,000 | 0.91% |